[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3660 Introduced in House (IH)]







105th CONGRESS
  2d Session
                                H. R. 3660

  To invest in the future of the United States by doubling the amount 
     authorized for basic scientific, medical, and pre-competitive 
                         engineering research.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 1, 1998

 Mr. Kennedy of Massachusetts (for himself, Mrs. Tauscher, Mr. Neal of 
   Massachusetts, Mr. Filner, Mr. Kucinich, Mr. McGovern, Mr. Romero-
   Barcelo, Mr. Gejdenson, Ms. Rivers, Ms. Woolsey, Mr. Frost, Mrs. 
     McCarthy of New York, Mr. Moran of Virginia, Mr. Snyder, Mr. 
Faleomavaega, Mr. LaTourette, Mr. Houghton, and Mr. Davis of Virginia) 
 introduced the following bill; which was referred to the Committee on 
      Science, and in addition to the Committees on Commerce, and 
Agriculture, for a period to be subsequently determined by the Speaker, 
 in each case for consideration of such provisions as fall within the 
                jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
  To invest in the future of the United States by doubling the amount 
     authorized for basic scientific, medical, and pre-competitive 
                         engineering research.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``National Research Investment Act of 
1998''.

SEC. 2. FINDINGS; PURPOSES.

    (a) Findings.--Congress finds that--
            (1) for fiscal year 1965, 5.7 percent of the Federal budget 
        was expended for nondefense research and development 
        activities;
            (2) for fiscal year 1997, the percentage of the Federal 
        budget allocated for nondefense research and development 
        activities is 1.9 percent, which is 67 percent less than the 
        percentage in fiscal year 1965;
            (3) for the first time in 25 years during the period 
        beginning with fiscal year 1992 and ending with fiscal year 
        1995, the amount of funds expended by the Federal Government on 
        research (expressed in real dollars) declined each year;
            (4) during the period beginning with fiscal year 1970, and 
        ending with fiscal year 1995, the United States had not, during 
        any fiscal year, expended an amount for nondefense research and 
        development activities, that, expressed as a percentage of the 
        Gross Domestic Product, was greater than or equal to the 
        percentage expended by Japan or Germany for that fiscal year; 
        and
            (5) an increased level of investment in basic scientific, 
        medical, and pre-competitive engineering research by the 
        Federal Government is essential to maintaining the position of 
        the United States as the technological leader of the world.
    (b) Purposes.--The purposes of this Act are as follows:
            (1) To double the annual authorized amount of Federal 
        funding for basic scientific, medical, and pre-competitive 
        engineering research over the 10-year period following the date 
        of enactment of this Act, so that the amount of Federal funding 
        for fiscal year 2008 is equal to $68,000,000,000.
            (2) To restore the high priority that science and 
        technology had previously been afforded in the Federal budget.
            (3) To invest in the future of the United States and the 
        people of the United States by expanding the research 
        activities referred to in paragraph (1).
            (4) To enhance the quality of life for all the people of 
        the United States.
            (5) To guarantee the leadership of the United States in 
        science, medicine, and technology.

SEC. 3. AUTHORIZATIONS OF APPROPRIATIONS.

    (a) Funds for Covered Research and Development Defined.--For 
purposes of this section, the term ``funds for covered research and 
development'' means--
            (1) any funds made available by appropriations for--
                    (A) the National Institutes of Health of the 
                Department of Health and Human Services;
                    (B) the National Science Foundation; and
                    (C) the National Institute for Standards and 
                Technology of the Department of Commerce;
            (2) any funds made available by appropriations for use for 
        research and development activities (as that term is used in 
        the most recent applicable appropriations Act with respect to a 
        Federal Agency) for basic scientific, medical, or pre-
        competitive engineering research--
                    (A) by the National Aeronautics and Space 
                Administration;
                    (B) by the National Oceanic and Atmospheric 
                Administration of the Department of Commerce;
                    (C) by the Centers for Disease Control and 
                Prevention of the Department of Health and Human 
                Services;
                    (D) by the Department of Energy (to the extent that 
                the activities are not defense-related activities);
                    (E) by the Department of Agriculture;
                    (F) by the Department of Veterans Affairs;
                    (G) by the Smithsonian Institution;
                    (H) by the Department of Education;
                    (I) by the Department of the Interior; and
                    (J) by the Department of Transportation; and
            (3) any funds made available by appropriations to the 
        Environmental Protection Agency for science and technology 
        activities for basic scientific, medical, or pre-competitive 
        engineering research.
    (b) Authorization of Appropriations.--
            (1) In general.--Subject to the limitations under paragraph 
        (2), there are authorized to be appropriated as funds for 
        covered research and development--
                    (A) for fiscal year 1999, $37,400,000,000, of which 
                $14,960,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services;
                    (B) for fiscal year 2000, $40,800,000,000, of which 
                $16,320,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services;
                    (C) for fiscal year 2001, $44,200,000,000, of which 
                $17,680,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services;
                    (D) for fiscal year 2002, $47,600,000,000, of which 
                $19,040,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services;
                    (E) for fiscal year 2003, $51,000,000,000, of which 
                $20,400,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services;
                    (F) for fiscal year 2004, $54,400,000,000, of which 
                $21,760,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services;
                    (G) for fiscal year 2005, $57,800,000,000, of which 
                $23,120,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services;
                    (H) for fiscal year 2006, $61,200,000,000, of which 
                $24,480,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services;
                    (I) for fiscal year 2007, $64,600,000,000, of which 
                $25,840,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services; and
                    (J) for fiscal year 2008, $68,000,000,000, of which 
                $27,200,000,000 shall be used by the National 
                Institutes of Health of the Department of Health and 
                Human Services.
            (2) Limitations.--
                    (A) Development of public information.--In using 
                funds made available under this section, the 
                appropriate officials shall take such action as may be 
                necessary to ensure that priority is given to basic 
                scientific, medical, and pre-competitive engineering 
                research that has the purpose of developing scientific 
                information to be available to the general public.
                    (B) Use of funds.--No funds made available pursuant 
                to the authorization under this subsection may be used 
                for commercial purposes, except that such funds may 
                only be used for pre-competitive research and 
                development for technology.
                    (C) Peer review.--In allocating funds made 
                available under this section, the appropriate officials 
                shall take such action as may be necessary to ensure 
                that a peer review system is used.

SEC. 4. COMPLIANCE WITH DISCRETIONARY CAPS.

    Notwithstanding any other provision of law, no funds may be made 
available under this Act in a manner that does not conform with the 
discretionary spending caps provided in the most recently adopted 
concurrent resolution on the budget.
                                 <all>